Innovation Pharmaceuticals Inc (IPIX)

[Waverunner1]

I think you are seriously confused here. The company has nearly the entire $30M still available from Aspire plus $8M cash. The two Phase 3 Brilacidin trials are estimated to cost between $10 and $12M. Rest assured, there will be no changing of hands of a Phase 3 asset like Brilacidin, unless of course we are talking about a collaboration deal. The notion that it could is simply ridiculous.

Who knows, maybe B changes hands 3 times before launching?